IONIS PHARMACEUTICALS INC reports

Company location: Carlsbad, CA
Fiscal year end: 31 December

IONIS PHARMACEUTICALS INC has filed 2,681 SEC EDGAR filings since 12 Jun 1996

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 376-400 of 1,000 matching filings.

Per page

25

Current page

16

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2025
Reporting date: 02 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2025
Reporting date: 02 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2025
Reporting date: 02 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2025
Reporting date: 02 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2025
Reporting date: 02 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2025
Reporting date: 02 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2025
Reporting date: 02 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2025
Reporting date: 02 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2025
Reporting date: 02 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jan 2025
Reporting date: 02 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 26 Dec 2024
Reporting date: 23 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-19125

8-K

Filing date: 20 Dec 2024
Reporting date: 19 Dec 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G/A File 005-41771

SC 13G/A

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 14 Nov 2024
Reporting date: 12 Nov 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 14 Nov 2024
Reporting date: 12 Nov 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 14 Nov 2024
Reporting date: 12 Nov 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-41771

SC 13G/A filing

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144/A File 000-19125

144/A filing

Filing date: 13 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 000-19125

144 filing

Filing date: 12 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 000-19125

144 filing

Filing date: 12 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 000-19125

144 filing

Filing date: 12 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-41771

SEC SCHEDULE 13G

Filing date: 08 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-19125

IONIS PHARMACEUTICALS, INC. 10-Q 9-30-2024

Filing date: 06 Nov 2024
Reporting date: 30 Sep 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-19125

8-K

Filing date: 06 Nov 2024
Reporting date: 06 Nov 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 17 Oct 2024
Reporting date: 15 Oct 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .